New Hormone Discovery Could Revolutionize Osteoporosis Treatment

Researchers identify CCN3, a hormone from the brain, that strengthens bones during lactation, offering potential therapeutic targets.

CCN3, dubbed the 'maternal brain hormone,' is produced in the hypothalamus and strengthens bones during breastfeeding.
The hormone has shown promise in improving bone repair in laboratory models and mice.
Current osteoporosis treatments are effective but not perfect, and CCN3 could provide a new approach.
Studies are ongoing to understand CCN3's broader applications beyond lactation.
The discovery underscores the importance of including female subjects in scientific research.